Immediate adverse reactions to acetaminophen in children: Evaluation of histamine release and spirometry

and a !ys!ne analogue (MK-521): disposition in man. Br J Clin Pharmacol 1982;14:357-62. 10. Hitchens M, Hand EL, Mulcahy WS. Radioimmunoassay for angiotensin converting enzyme inhibitors. Ligand Q 1981; 4:43. 11. Ferguson RK, Vlasses PH, Swanson BN, et al. Effects of enalapril, a new converting enzyme inhibitor, in hypertension. Clin Pharmacol Ther 1982;32:48-53. 12. Dickstein K, Till AE, Aarsland T, et al. The pharmacokinetics of enalapril in hospitalized patients with congestive heart failure. Br J Clin pharmacol 1987;23:403-10. 13. Biol!az J, Schelling JL, Des Combes J, et al. Enalapril maleate and a lysine analogue (MK-521) in normal volunteers: relationship between plasma drug levels and the renin angiotensin system. Br J Clin Pharmacol 1982;14:363-8. 14. Till AE, Gomez H J, Hichens M, et al. Pharmacokinetics of repeated single oral doses of enalapril maleate (MK-421) in normal volunteers. Biopharm Drug Dispos 1984;5:372-80. 15. Schwartz JB, Addison AT, Abernethy DR, et al. Altered pharmacokinetics and pharmacodynamics of enalapril in patients with congestive heart failure versus patients with hypertension [Abstract]. J Am Coil Cardiol 1985;5:544. 16. Shaddy RE, Teitel DF, Brett C. Short-term hemodynamic effects of eaptopril in infants with congestive heart failure. Am J Dis Child 1988;142:100-5. 17. Bengur AR, Beekman RH, Rocchini AP, et al. Hemodynamic effects of eaptopril in children with congestive or restrictive cardiomyopathy [Abstract]. J Am Coil Cardiol 1988; 11 (suppl A):28A. 18. Artman M, Graham TP. Guidelines for vasodilator therapy of congestive heart failure in infants and children. Am Heart J 1987;113:994-1005.